PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Dienogest - Endometriosis
PAD Profile : Dienogest - Endometriosis
Keywords :
Fibroids
Brand Names Include :
Zalkya, Dimetrum
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Guidelines (Local)
01 June 2025
Committee Recommendations
Date
Committee Name
Narrative
06 July 2022
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed dienogest as a treatment option, after the optimisation of other hormonal treatments, for the management of endometriosis and associated pain symptoms.
Dienogest will be given a BLUE (with information sheet) traffic light status. NOTE added in January 2025, treatment to be initiated and first 6 months treatment to be supplied by a specialist.
Associated BNF Codes
06. Endocrine System
06.04.01. Female sex hormones and their modulators